Conference on Phase I Clinical Trial Scheme of ImmuneOnco IMM0306 Project solemnly held

...

2019-08-05

Initiation Meeting of Phase I Clinical Trials of ImmuneOnco IMM01

Dr. Tian Wenzhi, founder of ImmuneOnco, and Director Qiu Lugui, Hospital of Hematology, Chinese Academy of Medical Sciences made opening remarks. Subsequently, the research team conducted in-depth and detailed discussions on the design of the re......

2019-08-02

2019 Team Building

...

2019-06-17

Celebration reception of IMM01 licensed for clinical trials

ImmuneOncoBiopharmaceuticals(Shanghai) Co., Ltd. was founded in Shanghai Zhangjiang High-tech Park in June 2015. The company is mainly committed to the development and research of cancer immunotherapy products, including monoclonal antibodies again......

2019-06-03

Authorized Use of ImmuneOnco’s FcR-TANK Cell Line

Our modified FcR-TANK cells can be well used for screening, functional analysis and release detection of antibiody drugs, and have the advantages of simple operation, short cycle, low cost and easy repetition. ...

2019-04-11